Jacobs appointed to M28 motorway project in Ireland

Jacobs has been selected by Cork County Council as technical advisor for the new M28 motorway in Ireland. 

The new road will link the N40 South Ring Road to the Port of Cork in Ringaskiddy, in County Cork. 

Jacobs’ scope includes consultancy services during the design, construction and closeout phases of the project. 

The proposed M28 Cork to Ringaskiddy motorway project is the upgrade of approximately 7.5 miles (12 km) of the N28 National Primary Route to help improve its safety, capacity and accessibility.

Forming part of the Core Trans‐European Transport Network, the Transport Infrastructure Ireland-funded scheme will enable the strategic development of the Port of Cork’s facilities in Ringaskiddy, while also supporting the economic development of the area locally, regionally and nationally. 

The motorway is scheduled to be completed by 2030.

Jacobs senior vice president Kate Kenny said: “Jacobs brings multi-disciplinary integration and delivery experience from a wide range of critical transportation infrastructure projects in Ireland and globally to support this project. 

“We’re focused on helping Cork County Council deliver an improved, user-centric, sustainable road network that connects communities more effectively, and drives important social and economic benefits in the region.” 

Cork County Council chief executive Valerie O’Sullivan added: “This development forms part of the government’s Project Ireland 2040 and will bring both safety and economic benefits. 

“The scheme includes a number of active travel measures with an interface with the Lee to Sea greenway, together with an extension to the existing Ballybrack Valley Pedestrian and Cycle Scheme in Douglas.”

Jacobs has more than 1,200 employees in Ireland serving clients in sectors – most notably advanced manufacturing, infrastructure, and energy and environment. 

Projects include the National Transport Authority’s BusConnects Dublin program,  Irish Rail’s East Coast Railway Infrastructure Protection Projects program, the WuXi Biologics Drug Substance Manufacturing Facility and Edwards Lifesciences Greenfield Manufacturing Facility.